Nasdaq · CIK 0001712762
BIAF bioAffinity Technologies, Inc.
Insider trading from SEC Form 4. Last filing Jan 14, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
2
with a Form 4 at this company
Signals
Open-market buys and sells at bioAffinity Technologies, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 3 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | James Michael Edwards VP and CFO | AGrant or award Common Stock | +6,172 | $0.00 | $0 | 120,128 | Jan 14, 2025 |
| Jan 10, 2025 | Steven Girgenti Executive Chairman | AGrant or award Common Stock | +14,814 | $0.00 | $0 | 1,080,062 | Jan 14, 2025 |
| Nov 5, 2024 | James Michael Edwards VP and CFO | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 113,956 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- James Michael EdwardsVP and CFO
- Steven GirgentiExecutive Chairman
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.